Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survival
Roberts, R.A.; Wright, G.; Rosenwald, A.R.; Jaramillo, M.A.; Grogan, T.M.; Miller, T.P.; Frutiger, Y.; Chan, W.C.; Gascoyne, R.D.; Ott, G.; Muller-Hermelink, H.Konrad.; Staudt, L.M.; Rimsza, L.M.
Blood 108(1): 311-318
2006
ISSN/ISBN: 0006-4971 PMID: 16543468 DOI: 10.1182/blood-2005-11-4742
Accession: 012275254
Loss of major histocompatibility class It (MHC II) expression in diffuse large B-cell lymphoma (DLBCL) correlates with worse outcome, possibly from decreased immunosurveillance. Primary mediastinal B-cell lymphoma (PMBCL) is a subtype of DLBCL which reportedly has frequent loss of MHC II proteins; however, PMBCL has better survival than DLBCL.
PDF emailed within 0-6 h: $19.90
Related References
Rimsza, L.; Roberts, R.; Campo, E.; Grogan, T.; Bea, S.; Salaverria, I.; Zettl, A.; Fisher, R.; Unger, J.; Leblanc, M.; Staudt, L.; Gascoyne, R.; Chan, W.; Weisenburger, D.; Greiner, T.; Jaffe, E.; Braziel, R.; Mueller Hermelink, K. 2003: Loss of major histocompatibility class II expression in nodal diffuse large B cell lymphoma is highly coordinated and unlikely related to chromosomal deletions Blood 102(11): 893aRimsza, L.M.; Roberts, R.A.; Miller, T.P.; Unger, J.M.; LeBlanc, M.; Braziel, R.M.; Weisenberger, D.D.; Chan, W.C.; Muller-Hermelink, H.Konrad.; Jaffe, E.S.; Gascoyne, R.D.; Campo, E.; Fuchs, D.A.; Spier, C.M.; Fisher, R.I.; Delabie, J.; Rosenwald, A.; Staudt, L.M.; Grogan, T.M. 2004: Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project Blood 103(11): 4251-4258
Rimsza, L.M.; Roberts, R.A.; Campo, E.; Grogan, T.M.; Bea, S.; Salaverria, I.; Zettl, A.; Rosenwald, A.; Ott, G.; Muller-Hermelink, H.K.; Delabie, J.; Fisher, R.I.; Unger, J.M.; Leblanc, M.; Staudt, L.M.; Jaffe, E.S.; Gascoyne, R.D.; Chan, W.C.; Weisenburger, D.D.; Greiner, T.; Braziel, R.M.; Miller, T.P. 2006: Loss of major histocompatibility class Ii expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions Blood 107(3): 1101-1107
Rimsza, L.M.; Leblanc, M.; Braziel, R.; Jaramillo, M.; Miller, T.P.; Staudt, L.; Grogan, T.M.; Fisher, R. 2003: Loss of major histocompatibility complex Class II gene expression predicts poor survival in diffuse large B celllymphoma Modern Pathology 16(1): 250A
Miller, T.P.; Leblanc, M.; Grogan, T.M.; Braziel, R.M.; Staudt, L.M.; Fisher, R.I. 2002: Major Histocompatibility Complex Class II Antigen HLA-DR Gene Expression Levels in Diffuse Large B-Cell Lymphoma Correlate with Survival Blood 100(11): Abstract No. 1341
Ait-Tahar, K.; Anderson, A.P.; Barnardo, M.; Collins, G.P.; Hatton, C.S.R.; Banham, A.H.; Pulford, K. 2017: Sp17 Protein Expression and Major Histocompatibility Class I and II Epitope Presentation in Diffuse Large B Cell Lymphoma Patients Advances in Hematology 2017: 6527306
Rimsza, L.M.; Chan, W.C.; Gascoyne, R.D.; Campo, E.; Jaffe, E.S.; Staudt, L.M.; Delabie, J.; Rosenwald, A.; Murphy, S.P. 2009: CIITA or RFX coding region loss of function mutations occur rarely in diffuse large B-cell lymphoma cases and cell lines with low levels of major histocompatibility complex class Ii expression Haematologica 94(4): 596-598
Moeller, P.; Laemmler, B.; Herrmann, B.; Otto, H.F.; Moldenhauer, G.; Momburg, F. 1986: The primary mediastinal clear cell lymphoma of b cell type has variable defects in major histocompatibility complex antigen expression Immunology 59(3): 411-418
Wilkinson, S.T.; Fernandez, D.R.; Murphy, S.P.; Braziel, R.M.; Campo, E.; Chan, W.C.; Delabie, J.; Gascoyne, R.D.; Staudt, L.M.; Jaffe, E.S.; Rosenwald, A.; Rimsza, L.M. 2009: Decreased major histocompatibility complex class Ii expression in diffuse large B-cell lymphoma does not correlate with CpG methylation of class Ii transactivator promoters IIi and IV Leukemia and Lymphoma 50(11): 1875-1878
Rao, S.; Lana, S.; Eickhoff, J.; Marcus, E.; Avery, P.R.; Morley, P.S.; Avery, A.C. 2011: Class Ii major histocompatibility complex expression and cell size independently predict survival in canine B-cell lymphoma Journal of Veterinary Internal Medicine 25(5): 1097-1105
Calvo, K.R.; Traverse-Glehen, A.; Pittaluga, S.; Jaffe, E.S. 2004: Molecular profiling provides evidence of primary mediastinal large B-cell lymphoma as a distinct entity related to classic Hodgkin lymphoma: implications for mediastinal gray zone lymphomas as an intermediate form of B-cell lymphoma Advances in Anatomic Pathology 11(5): 227-238
Wilkinson, S.T.; Vanpatten, K.A.; Fernandez, D.R.; Brunhoeber, P.; Garsha, K.E.; Glinsmann-Gibson, B.J.; Grogan, T.M.; Teruya-Feldstein, J.; Rimsza, L.M. 2012: Partial plasma cell differentiation as a mechanism of lost major histocompatibility complex class II expression in diffuse large B-cell lymphoma Blood 119(6): 1459-1467
Yildiz, S.M.; Atli, G.; Gulec, E.; Guvenc, B.; Ozcengiz, D. 2017: Major Histocompatibility Complex Class I-related Chain a and B Gene Expression in Sepsis Patient International Journal of Human Genetics 17(1): 26-30
Mottok, A.; Woolcock, B.; Chan, F.C.; Tong, K.M.; Chong, L.; Farinha, P.; Telenius, A.èl.; Chavez, E.; Ramchandani, S.; Drake, M.; Boyle, M.; Ben-Neriah, S.; Scott, D.W.; Rimsza, L.M.; Siebert, R.; Gascoyne, R.D.; Steidl, C. 2015: Genomic Alterations in CIITA Are Frequent in Primary Mediastinal Large B Cell Lymphoma and Are Associated with Diminished MHC Class Ii Expression Cell Reports 13(7): 1418-1431
Pittaluga, S.; Nicolae, A.; Wright, G.W.; Melani, C.; Roschewski, M.; Steinberg, S.; Huang, D.; Staudt, L.M.; Jaffe, E.S.; Wilson, W.H. 2020: Gene Expression Profiling of Mediastinal Gray Zone Lymphoma and its Relationship to Primary Mediastinal B-cell Lymphoma and Classical Hodgkin Lymphoma Blood Cancer Discovery 1(2): 155-161
Zhong, D.-r.; Ling, Q.; Shi, X.-h.; Liang, Z.-y.; Liu, T.-h. 2012: Comparative study between primary mediastinal B-cell lymphoma and non-mediastinal diffuse large B-cell lymphoma by immunoglobulin gene rearrangement and Epstein-Barr virus infection detection Zhonghua Bing Li Xue Za Zhi 41(6): 361-365
Kim, H.-J.; Kim, H.K.; Park, G.; Min, S.K.; Cha, H.J.; Lee, H.; Choi, S.J.; Na, H.Y.; Choe, J.-Y.; Kim, J.E. 2019: Comparative pathologic analysis of mediastinal B-cell lymphomas: selective expression of p63 but no GATA3 optimally differentiates primary mediastinal large B-cell lymphoma from classic Hodgkin lymphoma Diagnostic Pathology 14(1): 133
Kagoya, Y.; Nannya, Y.; Nakamura, F.; Kurokawa, M. 2014: Gene expression profiles of central nervous system lymphoma predict poor survival in patients with diffuse large B-cell lymphoma British Journal of Haematology 166(5): 794-797
Phipps-Yonas, H.; Cui, H.; Sebastiao, N.; Brunhoeber, P.S.; Haddock, E.; Deymier, M.J.; Klapper, W.; Lybarger, L.; Roe, D.J.; Hastings, K.T. 2013: Low GILT Expression is Associated with Poor Patient Survival in Diffuse Large B-Cell Lymphoma Frontiers in Immunology 4: 425
Rybski, J.A.; Spier, C.M.; Miller, T.P.; Mcgee, D.L.; Grogan, T.M. 1991: Prediction of outcome in diffuse large cell lymphoma by the major histocompatibility complex class i and class ii Laboratory Investigation 64(1): 83A